Effects of Bariatric Surgeries on the Size of Myocardial Infarction and Ghrelin Level in Rats with Experimental Decompensated Type 2 Diabetes Mellitus


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The effects of bariatric surgeries (sleeve gastrectomy and ileal transposition) on the dynamics of changes in ghrelin level were studied in rats with severe decompensated type 2 diabetes mellitus under conditions of glucose challenge as well as on the size of myocardial infarction in these animals. Diabetes was modelled by high fat diet and a single administration of streptozotocin (25 mg/kg, intraperitoneally). Both bariatric surgeries significantly decreased glucose-induced ghrelin level in the blood of rats with type 2 diabetes mellitus, which attested to an increase in the tissue sensitivity to ghrelin. Sleeve gastrectomy resulted in a decrease in the size of myocardial infarction in diabetic rats, which was calculated as the ratio of the necrosis zone to the zone of the risk of myocardial infarction. Ileal transposition had no effect on this parameter. Our data can be used as the basis for optimization of treatment approaches when using bariatric surgery in the treatment of patients with severe forms of type 2 diabetes mellitus with a high risk of cardiovascular diseases.

作者简介

O. Kornyushin

Institute of Experimental Medicine

编辑信件的主要联系方式.
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

D. Sonin

Institute of Experimental Medicine

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

Ya. Toropova

Institute of Experimental Medicine

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

E. Pochkaeva

Institute of Experimental Medicine

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

G. Semikova

I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

O. Berko

I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

I. Zelinskaya

Institute of Experimental Medicine

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

N. Todosenko

Laboratory of Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University

Email: o.kornyushin@gmail.com
俄罗斯联邦, Kaliningrad

L. Litvinova

Laboratory of Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University

Email: o.kornyushin@gmail.com
俄罗斯联邦, Kaliningrad

A. Neimark

Institute of Endocrinology, V. A. Almazov National Medical Research Center, Ministry of Health of the Russian Federation

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

A. Babenko

Institute of Endocrinology, V. A. Almazov National Medical Research Center, Ministry of Health of the Russian Federation

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

K. Dergach

Laboratory of Molecular Endocrinology and Neurochemistry, I. M. Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Sciences

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

A. Schpakov

Laboratory of Molecular Endocrinology and Neurochemistry, I. M. Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Sciences

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg

M. Galagudza

Institute of Experimental Medicine; I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation

Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg; St. Petersburg


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2019
##common.cookie##